Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
Little is known about the use of implantable cardioverter defibrillators and cardiac resynchronization devices in heart transplant recipients. A survey of 59 medical directors of heart transplant programs (response rate, 55.7%) found no clear consensus about indications for implantation of cardiac devices. A device was implanted in 44 recipients (38 with defibrillator alone), and 6 had an appropriate discharge during follow-up. There was an interest in establishing a registry to enable further study and analysis.
McDowell
Deryk L
DL
Division of Cardiology, Saint Louis University School of Medicine, St Louis, MO, USA.
Hauptman
Paul J
PJ
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000628:therapy*; D002304:Cardiac Pacing, Artificial; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D005260:Female; D019538:Health Care Surveys; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D014481:United States